EE9800037A - Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks - Google Patents

Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks

Info

Publication number: EE9800037A
Authority: EE; Estonia
Prior art keywords: pct; sulphonylcarbamates; acylsulphonamides; medicament; manufacture
Prior art date: 1995-08-04

Application number

EE9800037A

Other languages

English (en)

Estonian (et)

Inventor

Robert Krause Brian

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-04

Filing date

1996-07-08

Publication date

1998-08-17

1996-07-08 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

1998-08-17 Publication of EE9800037A publication Critical patent/EE9800037A/xx

Links

102000004895 Lipoproteins Human genes 0.000 title 1
108090001030 Lipoproteins Proteins 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 title 1
WZHRJGWXUCLILI-UHFFFAOYSA-N sulfonylcarbamic acid Chemical class OC(=O)N=S(=O)=O WZHRJGWXUCLILI-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 2
125000001624 naphthyl group Chemical group 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
208000006011 Stroke Diseases 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
208000026106 cerebrovascular disease Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
208000037803 restenosis Diseases 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
239000011593 sulfur Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EE9800037A 1995-08-04 1996-07-08 Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks EE9800037A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US303195P	1995-08-04	1995-08-04
PCT/US1996/011366 WO1997005868A1 (en)	1995-08-04	1996-07-08	Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (1)

Publication Number	Publication Date
EE9800037A true EE9800037A (et)	1998-08-17

Family

ID=21703764

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9800037A EE9800037A (et)	1995-08-04	1996-07-08	Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks

Country Status (27)

Country	Link
US (1)	US6117909A (de)
EP (1)	EP0841913B1 (de)
JP (1)	JPH11510184A (de)
KR (1)	KR19990036127A (de)
CN (1)	CN1192140A (de)
AT (1)	ATE232097T1 (de)
AU (1)	AU716255B2 (de)
BG (1)	BG63863B1 (de)
CA (1)	CA2221729A1 (de)
CZ (1)	CZ26198A3 (de)
DE (1)	DE69626118T2 (de)
DK (1)	DK0841913T3 (de)
EA (1)	EA002435B1 (de)
EE (1)	EE9800037A (de)
ES (1)	ES2191762T3 (de)
GE (1)	GEP20012511B (de)
HR (1)	HRP960341A2 (de)
HU (1)	HUP9900668A3 (de)
IL (1)	IL122247A0 (de)
NO (1)	NO980466L (de)
NZ (1)	NZ312571A (de)
PL (1)	PL185943B1 (de)
PT (1)	PT841913E (de)
SK (1)	SK12598A3 (de)
UA (1)	UA46030C2 (de)
WO (1)	WO1997005868A1 (de)
ZA (1)	ZA966617B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1584333A3 (de) *	1998-01-28	2009-04-29	Warner-Lambert Company LLC	Verwendung von Acetylcoenzyme A Inhibitoren zur Behandlung von Alzheimer
CN1310629A (zh) *	1998-07-21	2001-08-29	沃尼尔·朗伯公司	用于治疗动脉粥样硬化损伤的acat和mmp抑制剂的合并给药
IT1303249B1 (it) *	1998-10-23	2000-11-06	Dompe Spa	Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
HUP0203160A3 (en) *	1999-11-05	2006-02-28	Warner Lambert Co	Prevention of plaque rupture by acat inhibitors
CA2369967A1 (en) *	2001-02-12	2002-08-12	Joseph Anthony Cornicelli	Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es)	2001-10-05	2004-10-20	Novartis Ag	Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) *	2002-03-12	2005-09-06	Igt	Gaming device having varying risk player selections
KR102718287B1 (ko)	2017-11-14	2024-10-16	머크 샤프 앤드 돔 엘엘씨	인돌아민 2,3-디옥시게나제 (ido) 억제제로서의 신규 치환된 비아릴 화합물
WO2019099294A1 (en)	2017-11-14	2019-05-23	Merck Sharp & Dohme Corp.	Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5003106A (en) *	1983-07-19	1991-03-26	American Cyanamid Company	Antiatherosclerotic ureas and thioureas
US5245068A (en) *	1990-10-30	1993-09-14	Warner-Lambert Company	Oxysulfonyl carbamates
ES2067254T3 (es) *	1990-10-30	1995-03-16	Warner Lambert Co	Oxisulfonilcarbamatos.
IL101785A0 (en) *	1991-05-10	1992-12-30	Fujisawa Pharmaceutical Co	Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) *	1993-05-14	1996-02-13	Warner-Lambert Company	N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) *	1993-05-14	2001-01-11	Warner Lambert Co	Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

1996
- 1996-07-08 EA EA199800176A patent/EA002435B1/ru not_active IP Right Cessation
- 1996-07-08 DK DK96923687T patent/DK0841913T3/da active
- 1996-07-08 PL PL96324908A patent/PL185943B1/pl unknown
- 1996-07-08 HU HU9900668A patent/HUP9900668A3/hu unknown
- 1996-07-08 CA CA002221729A patent/CA2221729A1/en not_active Abandoned
- 1996-07-08 WO PCT/US1996/011366 patent/WO1997005868A1/en not_active Ceased
- 1996-07-08 EE EE9800037A patent/EE9800037A/xx unknown
- 1996-07-08 IL IL12224796A patent/IL122247A0/xx unknown
- 1996-07-08 ES ES96923687T patent/ES2191762T3/es not_active Expired - Lifetime
- 1996-07-08 CN CN96196033A patent/CN1192140A/zh active Pending
- 1996-07-08 AU AU64541/96A patent/AU716255B2/en not_active Ceased
- 1996-07-08 GE GEAP19964165A patent/GEP20012511B/en unknown
- 1996-07-08 US US09/000,296 patent/US6117909A/en not_active Expired - Fee Related
- 1996-07-08 KR KR1019980700795A patent/KR19990036127A/ko not_active Ceased
- 1996-07-08 PT PT96923687T patent/PT841913E/pt unknown
- 1996-07-08 DE DE69626118T patent/DE69626118T2/de not_active Expired - Fee Related
- 1996-07-08 SK SK125-98A patent/SK12598A3/sk unknown
- 1996-07-08 NZ NZ312571A patent/NZ312571A/en unknown
- 1996-07-08 EP EP96923687A patent/EP0841913B1/de not_active Expired - Lifetime
- 1996-07-08 AT AT96923687T patent/ATE232097T1/de not_active IP Right Cessation
- 1996-07-08 JP JP9508427A patent/JPH11510184A/ja active Pending
- 1996-07-08 CZ CZ98261A patent/CZ26198A3/cs unknown
- 1996-07-16 HR HR60/003,031A patent/HRP960341A2/hr not_active Application Discontinuation
- 1996-08-02 ZA ZA9606617A patent/ZA966617B/xx unknown
- 1996-08-07 UA UA97126430A patent/UA46030C2/uk unknown
1998
- 1998-01-30 BG BG102222A patent/BG63863B1/bg unknown
- 1998-02-03 NO NO980466A patent/NO980466L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP9900668A2 (hu)	1999-06-28
PL324908A1 (en)	1998-06-22
CA2221729A1 (en)	1997-02-20
UA46030C2 (uk)	2002-05-15
DE69626118T2 (de)	2003-11-27
CN1192140A (zh)	1998-09-02
KR19990036127A (ko)	1999-05-25
NO980466D0 (no)	1998-02-03
BG63863B1 (bg)	2003-04-30
ES2191762T3 (es)	2003-09-16
WO1997005868A1 (en)	1997-02-20
EA002435B1 (ru)	2002-04-25
HRP960341A2 (en)	1998-02-28
NO980466L (no)	1998-02-03
ATE232097T1 (de)	2003-02-15
US6117909A (en)	2000-09-12
IL122247A0 (en)	1998-04-05
EP0841913A1 (de)	1998-05-20
HUP9900668A3 (en)	2000-08-28
AU6454196A (en)	1997-03-05
GEP20012511B (en)	2001-08-27
EA199800176A1 (ru)	1998-10-29
PL185943B1 (pl)	2003-09-30
EP0841913B1 (de)	2003-02-05
CZ26198A3 (cs)	1998-07-15
ZA966617B (en)	1997-02-18
BG102222A (en)	1998-09-30
SK12598A3 (en)	1999-02-11
NZ312571A (en)	2000-07-28
PT841913E (pt)	2003-06-30
AU716255B2 (en)	2000-02-24
DE69626118D1 (de)	2003-03-13
DK0841913T3 (da)	2003-05-05
JPH11510184A (ja)	1999-09-07

Publication	Publication Date	Title
YU32100A (sh)	2003-02-28	Derivati hidrosamske kiseline kao inhibitori matrične metaloproteaze (mmp)
FI943948A0 (fi)	1994-08-26	Heterosykliset hiilihappojohdannaiset
CO5011115A1 (es)	2001-02-28	Compuestos y metodos quimioquina
ES2133163T3 (es)	1999-09-01	Esteres (o tioesteres) del acido n-acilsulfamico y esteres (o tioesteres) del acido n-sulfonilcarbamico como agentes hipercolesterolemicos.
ES2124545T3 (es)	1999-02-01	Azolidindionas como agentes antihiperglucemicos.
ATE218864T1 (de)	2002-06-15	Verwendung von piperidin-derivaten in der behandlung von schizophrenie
ES2141957T3 (es)	2000-04-01	Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
EE9800037A (et)	1998-08-17	Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks
ATE161725T1 (de)	1998-01-15	Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE69420832D1 (de)	1999-10-28	Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8
DE69227583D1 (de)	1998-12-17	Arylmorpholine, herstellung und verwendung
NO970340D0 (no)	1997-01-27	Organiske forbindelser
DE69512208D1 (de)	1999-10-21	Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
FI933492A0 (fi)	1993-08-06	Lipoxigenas inhiberande hydroxaminsyra- och n-hydroxiureaderivat
DE69616357D1 (de)	2001-11-29	Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
FR2700166B1 (fr)	1995-02-17	Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
MX9201288A (es)	1992-10-01	Metodo de tratamiento.
MX9709275A (es)	1998-03-29	Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
DE69421705D1 (de)	1999-12-23	Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
SE9401965D0 (sv)	1994-06-07	New compounds
MXPA04000139A (es)	2004-06-03	Uso de compuestos biciclo para tratar enfermedad de alzheimer.
DE69832796D1 (de)	2006-01-19	Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen